[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Fresenius Medical Care Ag ADR (FMS)

Fresenius Medical Care Ag ADR (FMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,305,474
  • Shares Outstanding, K 558,578
  • Annual Sales, $ 22,207 M
  • Annual Income, $ 1,107 M
  • EBIT $ 2,067 M
  • EBITDA $ 3,765 M
  • 60-Month Beta 0.81
  • Price/Sales 0.54
  • Price/Cash Flow 3.89
  • Price/Book 0.73

Options Overview Details

View History
  • Implied Volatility 77.97% (+8.41%)
  • Historical Volatility 41.15%
  • IV Percentile 55%
  • IV Rank 37.18%
  • IV High 163.32% on 02/11/26
  • IV Low 27.44% on 08/18/25
  • Expected Move (DTE 4) 2.08 (9.45%)
  • Put/Call Vol Ratio 0.46
  • Today's Volume 35
  • Volume Avg (30-Day) 46
  • Put/Call OI Ratio 2.69
  • Today's Open Interest 1,850
  • Open Int (30-Day) 2,087
  • Expected Range 19.95 to 24.11

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $0.52
  • Growth Rate Est. (year over year) +192,015.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.02 +10.04%
on 05/05/26
23.84 -7.59%
on 04/10/26
-1.40 (-5.98%)
since 04/08/26
3-Month
20.02 +10.04%
on 05/05/26
24.71 -10.85%
on 02/17/26
-2.05 (-8.51%)
since 02/06/26
52-Week
20.02 +10.04%
on 05/05/26
30.46 -27.68%
on 05/21/25
-6.04 (-21.52%)
since 05/08/25

Most Recent Stories

More News
Fresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of 5008X CAREsystems at speed

BAD HOMBURG, Germany , May 5, 2026 /PRNewswire/ -- "Fresenius Medical Care delivered continued operational and financial progress in the first quarter, with organic revenue growth, improved profitability...

FMS : 22.03 (+1.76%)
Fresenius Medical Care's Profitability Streak Meets the HDF Rollout Reality Check

Barchart Research What to Expect from FMS Earnings FMS Generated May 4, 2026 Current Price $22.65 EPS Estimate $$0.59 Consensus Rating Hold Average Move 4.55% Fresenius Medical Care's Profitability Streak...

FMS : 22.03 (+1.76%)
DaVita Stock: Is DVA Outperforming the Health Care Sector?

DaVita has outperformed the Health Care sector recently, but analysts are cautious about the stock’s prospects.

XLV : 143.49 (-0.85%)
FMS : 22.03 (+1.76%)
DVA : 198.65 (+1.22%)
Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band

BAD HOMBURG, Germany , Feb. 24, 2026 /PRNewswire/ -- "Fresenius Medical Care closed a milestone year marked by outstanding profitability gains. Over the past three years, we built a stronger and...

FMS : 22.03 (+1.76%)
Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned

BAD HOMBURG, Germany , Jan. 9, 2026 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal disease, will accelerate its share...

FMS : 22.03 (+1.76%)
Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board

BAD HOMBURG, Germany , Dec. 10, 2025 /PRNewswire/ -- The Supervisory Board of Fresenius Medical Care, the world's leading provider of products and services for individuals with renal disease, has...

FMS : 22.03 (+1.76%)
Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025

BAD HOMBURG, Germany , Nov. 4, 2025 /PRNewswire/ -- "In Q3 of 2025, we continued the momentum and further accelerated revenue growth. Conversion into operating income 2 growth increased as...

FMS : 22.03 (+1.76%)
Fresenius Medical Care highlights real-world advances in hemodiafiltration and AI at ASN Kidney Week 2025

BAD HOMBURG, Germany , Oct. 30, 2025 /PRNewswire/ -- Fresenius Medical Care AG (FME), the world's leading provider of products and services for people with kidney diseases, will present new research...

FMS : 22.03 (+1.76%)
Fresenius Medical Care (FMS) was downgraded to a Sell Rating at Bank of America Securities

Bank of America Securities analyst Marianne Bulot downgraded Fresenius Medical Care to a Sell today and set a price target of $22.00. The company’s shares opened today at $26.70.Elevate Your Investing...

FMS : 22.03 (+1.76%)
Bank of America Securities downgrades Fresenius Medical Care AG & Co. KGaA (0H9X) to a Sell

Fresenius Medical Care AG & Co. KGaA received a Sell rating and a €38.00 price target from Bank of America Securities analyst Anna Ractliffe today. The company’s shares closed yesterday at €47.55.Elevate...

FMS : 22.03 (+1.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable...

See More

Key Turning Points

3rd Resistance Point 22.73
2nd Resistance Point 22.47
1st Resistance Point 22.25
Last Price 22.03
1st Support Level 21.78
2nd Support Level 21.52
3rd Support Level 21.30

See More

52-Week High 30.46
Fibonacci 61.8% 26.47
Fibonacci 50% 25.24
Fibonacci 38.2% 24.01
Last Price 22.03
52-Week Low 20.02

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.